Yan Fei, Huo Qiang, Qiao Jun, Murat Vakeli, Ma Song-Feng
Department of Cardiac Surgery, The First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China.
Asian Cardiovasc Thorac Ann. 2008 Oct;16(5):361-5. doi: 10.1177/021849230801600504.
Sinus of Valsalva aneurysm is a rare anomaly. This study was designed to assess the long-term outcome of surgical repair of sinus of Valsalva aneurysm and factors influencing the prognosis. From August 1980 to August sinus of Valsalva aneurysm repair. Ventricular septal defect (42) and aortic regurgitation (34) were the most frequent coexisting anomalies. An approach via the involved chamber was used in 60 patients, aortotomy in 5, and a combined approach in 35. Either direct (43) or patch (57) closure was used to repair the defect. Aortic valve replacement was required in 14 patients, and 8 needed valvuloplasty. Eighty patients were followed up for 15.6 +/- 3.9 years. There were 3 hospital deaths and 2 late deaths. New York Heart Association functional class improved significantly after surgery. Actuarial survival was 94% at 10 years, and 90% at 15 years. Surgical treatment of sinus of Valsalva aneurysm is safe and effective, but late progressive aortic regurgitation is still a risk during long-term follow-up, and early aggressive measures are recommended.
瓦氏窦瘤是一种罕见的先天性异常。本研究旨在评估瓦氏窦瘤手术修复的长期效果以及影响预后的因素。从1980年8月至[此处原文缺失年份]8月进行了瓦氏窦瘤修复手术。室间隔缺损(42例)和主动脉瓣反流(34例)是最常见的并存异常。60例患者采用经受累腔室的入路,5例采用主动脉切开术,35例采用联合入路。采用直接缝合(43例)或补片修补(57例)修复缺损。14例患者需要进行主动脉瓣置换,8例需要进行瓣膜成形术。80例患者接受了15.6±3.9年的随访。有3例住院死亡和2例晚期死亡。术后纽约心脏协会心功能分级显著改善。10年的精算生存率为94%,15年为90%。瓦氏窦瘤的手术治疗安全有效,但在长期随访中晚期进行性主动脉瓣反流仍然是一种风险,建议早期采取积极措施。